Compass Therapeutics Inc [CMPX] stock Initiated by Guggenheim analyst, price target now $12
Compass Therapeutics Inc [NASDAQ: CMPX] gained 17.89% or 0.34 points to close at $2.24 with a heavy trading volume of 22337677 shares. The daily chart for CMPX points out that the company has recorded 19.15% gains over the past six months. If we look at